Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of Hold by Analysts

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has been given a consensus rating of “Hold” by the nine analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average […]

Related Keywords

Hong Kong ,Pascal Touchon ,Us Bancorp ,Securities Exchange Commission ,Nisa Investment Advisors ,Hong Kong Ltd ,Nasdaq ,First Republic Investment Management Inc ,Ef Hutton Acquisition Co ,Tower Research Capital ,Atara Biotherapeutics Inc ,Get Rating ,Marketbeat Ratings ,Exchange Commission ,Investment Advisors ,Kong Ltd ,Research Capital ,First Republic Investment Management ,Atara Biotherapeutics ,Nasdaq Atra ,Tatra ,Medical ,Ratings ,Consensus ,